Estimation with Tc-99m tetrofosmin SPECT of salvaged myocardial mass after emergent reperfusion therapy in acute myocardial infarction
The purpose of this study was to validate a new quantitative index of salvaged myocardial mass calculated from Tc-99m tetrofosmin SPECT for evaluating the therapeutic effect of emergent reperfusion therapy in acute myocardial infarction (AMI). Tc-99m tetrofosmin SPECT was performed before and after...
Gespeichert in:
| Veröffentlicht in: | Annals of nuclear medicine 2003-12, Vol.17 (8), p.717-723 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 723 |
|---|---|
| container_issue | 8 |
| container_start_page | 717 |
| container_title | Annals of nuclear medicine |
| container_volume | 17 |
| creator | Okizaki, Atsutaka Shuke, Noriyuki Fujita, Tsutomu Koshiyama, Hiroaki Enomoto, Morio Yamazaki, Seiji Nigo, Takahiro Kurihara, Tamiko Aburano, Tamio |
| description | The purpose of this study was to validate a new quantitative index of salvaged myocardial mass calculated from Tc-99m tetrofosmin SPECT for evaluating the therapeutic effect of emergent reperfusion therapy in acute myocardial infarction (AMI).
Tc-99m tetrofosmin SPECT was performed before and after emergent percutaneous transluminal coronary angioplasty (PTCA) in eight patients with AMI. In the pre-PTCA study, Tc-99m tetrofosmin was injected before emergent PTCA. Two weeks after the PTCA, post-PTCA study was performed. As a quantitative index of salvaged myocardial mass, salvaged myocardial volume (SMV) was defined as the difference of myocardial functional volume between the SPECT studies before and after the PTCA. To investigate the clinical significance of SMV, SMV was compared with the grade of therapeutic efficacy determined visually from pre- and post-PTCA SPECT images and clinical parameters, namely peak creatine phosphokinase level (pCK) and the time from the onset of the AMI to reperfusion (RPT).
SMV showed a significant correlation with the visual grade of therapeutic efficacy (r = 0.737, p < 0.037) and a trend toward significant correlation with pCK (r = -0.622, p < 0.1). SMVs in early- and late-reperfusion groups (RPT < or = 6 hr and RPT > 6 hr) were 30.0 +/- 14.0 and -6.2 +/- 25.5 ml, showing a greater mean SMV value in the early-reperfusion group (p < 0.07).
SMV could be used as a quantitative index of salvaged myocardial mass for evaluating the therapeutic effect of emergent reperfusion therapy. |
| doi_str_mv | 10.1007/BF02984982 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71533740</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2787250016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-77c522fb2f3f12269463f84662a460c2a7d491f55c278f65f38e9f59a587a2853</originalsourceid><addsrcrecordid>eNqFkV1rE0EUhgdRbKze-APKoNALYet8f1zWkKhQqGC8XqaTM-2W3Z10ZlbJH-jv7oQEIgXx6tw85znn5UXoPSUXlBD9-cuSMGuENewFmlGjRKME5y_RjFgqGk2NPkFvcr4nhBlp2Gt0QoXVVFE7Q4-LXLrBlS6O-E9X7vDKN9YOuEBJMcQ8dCP--WMxX-EYcHb9b3cLazxso3dp3bkeDy5n7EKBhGGAdAtjwQk2kMKUd9JyB8lttrh6nJ8K_L3bjcElv7v9Fr0Krs_w7jBP0a_lYjX_1lxdf_0-v7xqvJCmNFp7yVi4YYEHypiyQvFghFLMCUU8c3otLA1SeqZNUDJwAzZI66TRrobnp-h8792k-DBBLu3QZQ9970aIU241lZxrQf4LMkpZhW0FPz4D7-OUxhqirT9oJgmhqlIf_klRSYQQZKf6tId8ijknCO0m1W7StqWk3TXdHpuu8NnBON0MsD6ih2r5E5wOoj8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>215044409</pqid></control><display><type>article</type><title>Estimation with Tc-99m tetrofosmin SPECT of salvaged myocardial mass after emergent reperfusion therapy in acute myocardial infarction</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>SpringerLink Journals - AutoHoldings</source><creator>Okizaki, Atsutaka ; Shuke, Noriyuki ; Fujita, Tsutomu ; Koshiyama, Hiroaki ; Enomoto, Morio ; Yamazaki, Seiji ; Nigo, Takahiro ; Kurihara, Tamiko ; Aburano, Tamio</creator><creatorcontrib>Okizaki, Atsutaka ; Shuke, Noriyuki ; Fujita, Tsutomu ; Koshiyama, Hiroaki ; Enomoto, Morio ; Yamazaki, Seiji ; Nigo, Takahiro ; Kurihara, Tamiko ; Aburano, Tamio</creatorcontrib><description>The purpose of this study was to validate a new quantitative index of salvaged myocardial mass calculated from Tc-99m tetrofosmin SPECT for evaluating the therapeutic effect of emergent reperfusion therapy in acute myocardial infarction (AMI).
Tc-99m tetrofosmin SPECT was performed before and after emergent percutaneous transluminal coronary angioplasty (PTCA) in eight patients with AMI. In the pre-PTCA study, Tc-99m tetrofosmin was injected before emergent PTCA. Two weeks after the PTCA, post-PTCA study was performed. As a quantitative index of salvaged myocardial mass, salvaged myocardial volume (SMV) was defined as the difference of myocardial functional volume between the SPECT studies before and after the PTCA. To investigate the clinical significance of SMV, SMV was compared with the grade of therapeutic efficacy determined visually from pre- and post-PTCA SPECT images and clinical parameters, namely peak creatine phosphokinase level (pCK) and the time from the onset of the AMI to reperfusion (RPT).
SMV showed a significant correlation with the visual grade of therapeutic efficacy (r = 0.737, p < 0.037) and a trend toward significant correlation with pCK (r = -0.622, p < 0.1). SMVs in early- and late-reperfusion groups (RPT < or = 6 hr and RPT > 6 hr) were 30.0 +/- 14.0 and -6.2 +/- 25.5 ml, showing a greater mean SMV value in the early-reperfusion group (p < 0.07).
SMV could be used as a quantitative index of salvaged myocardial mass for evaluating the therapeutic effect of emergent reperfusion therapy.</description><identifier>ISSN: 0914-7187</identifier><identifier>EISSN: 1864-6433</identifier><identifier>DOI: 10.1007/BF02984982</identifier><identifier>PMID: 14971619</identifier><language>eng</language><publisher>Japan: Springer Nature B.V</publisher><subject>Aged ; Aged, 80 and over ; Angioplasty ; Angioplasty, Balloon, Coronary - adverse effects ; Creatine ; Creatine kinase ; Effectiveness ; Female ; Heart attacks ; Humans ; Image Interpretation, Computer-Assisted - methods ; Male ; Middle Aged ; Myocardial infarction ; Myocardial Infarction - complications ; Myocardial Infarction - diagnostic imaging ; Myocardial Infarction - surgery ; Myocardial Reperfusion Injury - diagnostic imaging ; Myocardial Reperfusion Injury - etiology ; Myocardial Stunning - diagnostic imaging ; Myocardial Stunning - etiology ; Organophosphorus Compounds ; Organotechnetium Compounds ; Radiopharmaceuticals ; Reperfusion ; Reproducibility of Results ; Sensitivity and Specificity ; Severity of Illness Index ; Single photon emission computed tomography ; Statistics as Topic ; Therapy ; Tomography, Emission-Computed, Single-Photon - methods ; Treatment Outcome</subject><ispartof>Annals of nuclear medicine, 2003-12, Vol.17 (8), p.717-723</ispartof><rights>Springer 2003</rights><rights>Springer 2003.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-77c522fb2f3f12269463f84662a460c2a7d491f55c278f65f38e9f59a587a2853</citedby><cites>FETCH-LOGICAL-c458t-77c522fb2f3f12269463f84662a460c2a7d491f55c278f65f38e9f59a587a2853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14971619$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okizaki, Atsutaka</creatorcontrib><creatorcontrib>Shuke, Noriyuki</creatorcontrib><creatorcontrib>Fujita, Tsutomu</creatorcontrib><creatorcontrib>Koshiyama, Hiroaki</creatorcontrib><creatorcontrib>Enomoto, Morio</creatorcontrib><creatorcontrib>Yamazaki, Seiji</creatorcontrib><creatorcontrib>Nigo, Takahiro</creatorcontrib><creatorcontrib>Kurihara, Tamiko</creatorcontrib><creatorcontrib>Aburano, Tamio</creatorcontrib><title>Estimation with Tc-99m tetrofosmin SPECT of salvaged myocardial mass after emergent reperfusion therapy in acute myocardial infarction</title><title>Annals of nuclear medicine</title><addtitle>Ann Nucl Med</addtitle><description>The purpose of this study was to validate a new quantitative index of salvaged myocardial mass calculated from Tc-99m tetrofosmin SPECT for evaluating the therapeutic effect of emergent reperfusion therapy in acute myocardial infarction (AMI).
Tc-99m tetrofosmin SPECT was performed before and after emergent percutaneous transluminal coronary angioplasty (PTCA) in eight patients with AMI. In the pre-PTCA study, Tc-99m tetrofosmin was injected before emergent PTCA. Two weeks after the PTCA, post-PTCA study was performed. As a quantitative index of salvaged myocardial mass, salvaged myocardial volume (SMV) was defined as the difference of myocardial functional volume between the SPECT studies before and after the PTCA. To investigate the clinical significance of SMV, SMV was compared with the grade of therapeutic efficacy determined visually from pre- and post-PTCA SPECT images and clinical parameters, namely peak creatine phosphokinase level (pCK) and the time from the onset of the AMI to reperfusion (RPT).
SMV showed a significant correlation with the visual grade of therapeutic efficacy (r = 0.737, p < 0.037) and a trend toward significant correlation with pCK (r = -0.622, p < 0.1). SMVs in early- and late-reperfusion groups (RPT < or = 6 hr and RPT > 6 hr) were 30.0 +/- 14.0 and -6.2 +/- 25.5 ml, showing a greater mean SMV value in the early-reperfusion group (p < 0.07).
SMV could be used as a quantitative index of salvaged myocardial mass for evaluating the therapeutic effect of emergent reperfusion therapy.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angioplasty</subject><subject>Angioplasty, Balloon, Coronary - adverse effects</subject><subject>Creatine</subject><subject>Creatine kinase</subject><subject>Effectiveness</subject><subject>Female</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>Image Interpretation, Computer-Assisted - methods</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardial infarction</subject><subject>Myocardial Infarction - complications</subject><subject>Myocardial Infarction - diagnostic imaging</subject><subject>Myocardial Infarction - surgery</subject><subject>Myocardial Reperfusion Injury - diagnostic imaging</subject><subject>Myocardial Reperfusion Injury - etiology</subject><subject>Myocardial Stunning - diagnostic imaging</subject><subject>Myocardial Stunning - etiology</subject><subject>Organophosphorus Compounds</subject><subject>Organotechnetium Compounds</subject><subject>Radiopharmaceuticals</subject><subject>Reperfusion</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><subject>Severity of Illness Index</subject><subject>Single photon emission computed tomography</subject><subject>Statistics as Topic</subject><subject>Therapy</subject><subject>Tomography, Emission-Computed, Single-Photon - methods</subject><subject>Treatment Outcome</subject><issn>0914-7187</issn><issn>1864-6433</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkV1rE0EUhgdRbKze-APKoNALYet8f1zWkKhQqGC8XqaTM-2W3Z10ZlbJH-jv7oQEIgXx6tw85znn5UXoPSUXlBD9-cuSMGuENewFmlGjRKME5y_RjFgqGk2NPkFvcr4nhBlp2Gt0QoXVVFE7Q4-LXLrBlS6O-E9X7vDKN9YOuEBJMcQ8dCP--WMxX-EYcHb9b3cLazxso3dp3bkeDy5n7EKBhGGAdAtjwQk2kMKUd9JyB8lttrh6nJ8K_L3bjcElv7v9Fr0Krs_w7jBP0a_lYjX_1lxdf_0-v7xqvJCmNFp7yVi4YYEHypiyQvFghFLMCUU8c3otLA1SeqZNUDJwAzZI66TRrobnp-h8792k-DBBLu3QZQ9970aIU241lZxrQf4LMkpZhW0FPz4D7-OUxhqirT9oJgmhqlIf_klRSYQQZKf6tId8ijknCO0m1W7StqWk3TXdHpuu8NnBON0MsD6ih2r5E5wOoj8</recordid><startdate>20031201</startdate><enddate>20031201</enddate><creator>Okizaki, Atsutaka</creator><creator>Shuke, Noriyuki</creator><creator>Fujita, Tsutomu</creator><creator>Koshiyama, Hiroaki</creator><creator>Enomoto, Morio</creator><creator>Yamazaki, Seiji</creator><creator>Nigo, Takahiro</creator><creator>Kurihara, Tamiko</creator><creator>Aburano, Tamio</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20031201</creationdate><title>Estimation with Tc-99m tetrofosmin SPECT of salvaged myocardial mass after emergent reperfusion therapy in acute myocardial infarction</title><author>Okizaki, Atsutaka ; Shuke, Noriyuki ; Fujita, Tsutomu ; Koshiyama, Hiroaki ; Enomoto, Morio ; Yamazaki, Seiji ; Nigo, Takahiro ; Kurihara, Tamiko ; Aburano, Tamio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-77c522fb2f3f12269463f84662a460c2a7d491f55c278f65f38e9f59a587a2853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angioplasty</topic><topic>Angioplasty, Balloon, Coronary - adverse effects</topic><topic>Creatine</topic><topic>Creatine kinase</topic><topic>Effectiveness</topic><topic>Female</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>Image Interpretation, Computer-Assisted - methods</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardial infarction</topic><topic>Myocardial Infarction - complications</topic><topic>Myocardial Infarction - diagnostic imaging</topic><topic>Myocardial Infarction - surgery</topic><topic>Myocardial Reperfusion Injury - diagnostic imaging</topic><topic>Myocardial Reperfusion Injury - etiology</topic><topic>Myocardial Stunning - diagnostic imaging</topic><topic>Myocardial Stunning - etiology</topic><topic>Organophosphorus Compounds</topic><topic>Organotechnetium Compounds</topic><topic>Radiopharmaceuticals</topic><topic>Reperfusion</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><topic>Severity of Illness Index</topic><topic>Single photon emission computed tomography</topic><topic>Statistics as Topic</topic><topic>Therapy</topic><topic>Tomography, Emission-Computed, Single-Photon - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okizaki, Atsutaka</creatorcontrib><creatorcontrib>Shuke, Noriyuki</creatorcontrib><creatorcontrib>Fujita, Tsutomu</creatorcontrib><creatorcontrib>Koshiyama, Hiroaki</creatorcontrib><creatorcontrib>Enomoto, Morio</creatorcontrib><creatorcontrib>Yamazaki, Seiji</creatorcontrib><creatorcontrib>Nigo, Takahiro</creatorcontrib><creatorcontrib>Kurihara, Tamiko</creatorcontrib><creatorcontrib>Aburano, Tamio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okizaki, Atsutaka</au><au>Shuke, Noriyuki</au><au>Fujita, Tsutomu</au><au>Koshiyama, Hiroaki</au><au>Enomoto, Morio</au><au>Yamazaki, Seiji</au><au>Nigo, Takahiro</au><au>Kurihara, Tamiko</au><au>Aburano, Tamio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Estimation with Tc-99m tetrofosmin SPECT of salvaged myocardial mass after emergent reperfusion therapy in acute myocardial infarction</atitle><jtitle>Annals of nuclear medicine</jtitle><addtitle>Ann Nucl Med</addtitle><date>2003-12-01</date><risdate>2003</risdate><volume>17</volume><issue>8</issue><spage>717</spage><epage>723</epage><pages>717-723</pages><issn>0914-7187</issn><eissn>1864-6433</eissn><abstract>The purpose of this study was to validate a new quantitative index of salvaged myocardial mass calculated from Tc-99m tetrofosmin SPECT for evaluating the therapeutic effect of emergent reperfusion therapy in acute myocardial infarction (AMI).
Tc-99m tetrofosmin SPECT was performed before and after emergent percutaneous transluminal coronary angioplasty (PTCA) in eight patients with AMI. In the pre-PTCA study, Tc-99m tetrofosmin was injected before emergent PTCA. Two weeks after the PTCA, post-PTCA study was performed. As a quantitative index of salvaged myocardial mass, salvaged myocardial volume (SMV) was defined as the difference of myocardial functional volume between the SPECT studies before and after the PTCA. To investigate the clinical significance of SMV, SMV was compared with the grade of therapeutic efficacy determined visually from pre- and post-PTCA SPECT images and clinical parameters, namely peak creatine phosphokinase level (pCK) and the time from the onset of the AMI to reperfusion (RPT).
SMV showed a significant correlation with the visual grade of therapeutic efficacy (r = 0.737, p < 0.037) and a trend toward significant correlation with pCK (r = -0.622, p < 0.1). SMVs in early- and late-reperfusion groups (RPT < or = 6 hr and RPT > 6 hr) were 30.0 +/- 14.0 and -6.2 +/- 25.5 ml, showing a greater mean SMV value in the early-reperfusion group (p < 0.07).
SMV could be used as a quantitative index of salvaged myocardial mass for evaluating the therapeutic effect of emergent reperfusion therapy.</abstract><cop>Japan</cop><pub>Springer Nature B.V</pub><pmid>14971619</pmid><doi>10.1007/BF02984982</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0914-7187 |
| ispartof | Annals of nuclear medicine, 2003-12, Vol.17 (8), p.717-723 |
| issn | 0914-7187 1864-6433 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71533740 |
| source | MEDLINE; Alma/SFX Local Collection; SpringerLink Journals - AutoHoldings |
| subjects | Aged Aged, 80 and over Angioplasty Angioplasty, Balloon, Coronary - adverse effects Creatine Creatine kinase Effectiveness Female Heart attacks Humans Image Interpretation, Computer-Assisted - methods Male Middle Aged Myocardial infarction Myocardial Infarction - complications Myocardial Infarction - diagnostic imaging Myocardial Infarction - surgery Myocardial Reperfusion Injury - diagnostic imaging Myocardial Reperfusion Injury - etiology Myocardial Stunning - diagnostic imaging Myocardial Stunning - etiology Organophosphorus Compounds Organotechnetium Compounds Radiopharmaceuticals Reperfusion Reproducibility of Results Sensitivity and Specificity Severity of Illness Index Single photon emission computed tomography Statistics as Topic Therapy Tomography, Emission-Computed, Single-Photon - methods Treatment Outcome |
| title | Estimation with Tc-99m tetrofosmin SPECT of salvaged myocardial mass after emergent reperfusion therapy in acute myocardial infarction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T19%3A54%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Estimation%20with%20Tc-99m%20tetrofosmin%20SPECT%20of%20salvaged%20myocardial%20mass%20after%20emergent%20reperfusion%20therapy%20in%20acute%20myocardial%20infarction&rft.jtitle=Annals%20of%20nuclear%20medicine&rft.au=Okizaki,%20Atsutaka&rft.date=2003-12-01&rft.volume=17&rft.issue=8&rft.spage=717&rft.epage=723&rft.pages=717-723&rft.issn=0914-7187&rft.eissn=1864-6433&rft_id=info:doi/10.1007/BF02984982&rft_dat=%3Cproquest_cross%3E2787250016%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=215044409&rft_id=info:pmid/14971619&rfr_iscdi=true |